Canada Markets close in 1 hr 19 mins

InnoCan Pharma Corporation (INNO.CN)

Canadian Sec - Canadian Sec Real Time Price. Currency in CAD
Add to watchlist
0.2950+0.0050 (+1.72%)
As of 11:24AM EST. Market open.
Currency in CAD

Valuation Measures4

Market Cap (intraday) N/A
Enterprise Value N/A
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/Sales (ttm)N/A
Price/Book (mrq)N/A
Enterprise Value/Revenue N/A
Enterprise Value/EBITDA N/A

Trading Information

Stock Price History

Beta (5Y Monthly) 3.84
52-Week Change 3N/A
S&P500 52-Week Change 3N/A
52 Week High 30.8500
52 Week Low 30.1950
50-Day Moving Average 30.2833
200-Day Moving Average 30.4162

Share Statistics

Avg Vol (3 month) 344.36k
Avg Vol (10 day) 354.17k
Shares Outstanding 5234.62M
Implied Shares Outstanding 6N/A
Float 8174.08M
% Held by Insiders 128.43%
% Held by Institutions 10.21%
Shares Short (Sept 14, 2022) 422.61k
Short Ratio (Sept 14, 2022) 40.6
Short % of Float (Sept 14, 2022) 4N/A
Short % of Shares Outstanding (Sept 14, 2022) 40.01%
Shares Short (prior month Aug 14, 2022) 446.19k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 2N/A
Last Split Date 3N/A

Financial Highlights

Currency in USD.

Fiscal Year

Fiscal Year Ends Dec 30, 2021
Most Recent Quarter (mrq)Jun 29, 2022

Profitability

Profit Margin 0.00%
Operating Margin (ttm)-1,032.62%

Management Effectiveness

Return on Assets (ttm)-63.34%
Return on Equity (ttm)-154.16%

Income Statement

Revenue (ttm)745k
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)366.30%
Gross Profit (ttm)121k
EBITDA -7.65M
Net Income Avi to Common (ttm)-6.58M
Diluted EPS (ttm)-0.0750
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)7.73M
Total Cash Per Share (mrq)0.03
Total Debt (mrq)12k
Total Debt/Equity (mrq)0.17
Current Ratio (mrq)4.07
Book Value Per Share (mrq)-0.02

Cash Flow Statement

Operating Cash Flow (ttm)-7.04M
Levered Free Cash Flow (ttm)-5.51M